Salzburg, Austria

Sandra Scheiblhofer

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Biontech Rna Pharmaceuticals Gmbh. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sandra Scheiblhofer. Retrieved from https://idiyas.com/inventor/sandra-scheiblhofer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sandra Scheiblhofer: RNA Vaccine Inventor

Introduction

Sandra Scheiblhofer is an inventor associated with Salzburg, Austria. Her patent work includes an RNA vaccine concept designed to encode an allergen or a derivative of an allergen.

Latest Patents

The provided information lists one patent for Scheiblhofer: “RNA Vaccines.” It describes an RNA vaccine containing an RNA molecule that encodes an allergen or a derivative thereof. The available description does not specify which allergen is encoded.

Career Highlights

Scheiblhofer has been associated with BioNTech RNA Pharmaceuticals GmbH and Biomay AG. Her listed patent reflects research into RNA-based approaches to allergen-related applications.

Collaborations

The provided information names Angelika Fruhwirth and Richard Weiss as Scheiblhofer’s coworkers.

Conclusion

Sandra Scheiblhofer’s listed invention concerns an RNA vaccine encoding an allergen or its derivative, and her career is associated with BioNTech RNA Pharmaceuticals GmbH and Biomay AG.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…